- 2020 American Transplant Congress - ANG-3777, A Hepatic Growth Factor Mimetic, Attenuates Post-Transplant Renal Dysfunction in Rats- Angion Biomedica, Uniondale, NY *Purpose: ANG-3777, a small-molecule mimetic of hepatocyte growth factor (HGF), has the potential to exert antifibrotic and nephroprotective effects. A rat model of renal transplantation…
- 2020 American Transplant Congress - Preformed Donor Specific Antibody and Mfi-Dependent Effects in Simultaneous Liver-Kidney Transplantation- Department of Transplantation, University of Wisconsin, Madison, WI *Purpose: Preformed donor specific antibody to HLA Class II (pDSA) is suggested to be an independent risk factor for mortality in simultaneous liver and kidney…
- 2020 American Transplant Congress - Sleep Quality and Psychosocial Factors in Liver Transplant Recipients from an Outpatient Follow-Up Clinic in China- Transplantation Center, Third Xiangya Hospital, Changsha, China *Purpose: Sleep disturbance is a severe problem in liver transplant recipients; few studies have confirmed the psychosocial factors associated with sleep quality in patients after…
- 2020 American Transplant Congress - Perspectives of Nephrologists and Urologists on Financial Incentives for Altruistic Non-Directed Living Kidney Donors*Purpose: Several strategies have been suggested to remove financial barriers that can arise from donating a kidney, including payment in the form of incentives, rewards…
- 2020 American Transplant Congress - Socio-Demographic Disparities in Access to Organs from HCV-Viremic Donors among HCV-Negative Patients*Purpose: The success of pilot trials of transplanting organs from hepatitis C virus (HCV) viremic donors into HCV-negative recipients (HCV D+/R-) has led to an…
- 2020 American Transplant Congress - Comparing Early Kidney after Liver Transplant (KALT) and Simultaneous Liver-Kidney Transplant (SLK): Evaluating Racial Disparities. Will Everyone Have the Same “Safety Net”?*Purpose: In 2017, UNOS implemented simultaneous liver-kidney transplant (SLK) guidelines that included medical eligibility criteria and a “safety net” providing prioritization on the kidney transplant…
- 2020 American Transplant Congress - Belatacept in Kidney Transplant Recipients with Previous Non-Renal Solid Organ Transplants- Emory Transplant Center, Emory University School of Medicine, Atlanta, GA *Purpose: Selective co-stimulatory blockade with belatacept has demonstrated long-term benefits in renal transplantation, with improved glomerular filtration rate and decreased risk of death and graft…
- 2020 American Transplant Congress - New Strategy to Maximize Nanomedicine Delivery During Ex Vivo Organ Perfusion*Purpose: Organ transplant is a highly successful therapy for patients facing end stage organ failure. However, there is a severe lack of transplantable organs which…
- 2020 American Transplant Congress - Successful Liver-Kidney Transplantation in a Highly Sensitized Pediatric Patient- Children's Hospital Colorado, Denver, CO *Purpose: While immunologically challenging and controversial, we report a successful case of same donor staged simultaneous liver-kidney transplant (SLK) in a highly sensitized child against…
- 2020 American Transplant Congress - Effect of JC Virus on Polyomavirus Nephropathy in Renal Transplant Recipients- The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China *Purpose: To investigate the effect of JC virus (JCV) on the development and prognosis of BK virus (BKV) infection and polyomavirus nephropathy (PVN) in renal…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 24
- Next Page »
